沃森生物成立新公司 含生物基材料制造业务

Core Viewpoint - Watson Bio (300142) has established a new subsidiary, Watson Bio (Kunming) Co., Ltd., with a registered capital of 40 million yuan, focusing on various biotechnological developments and applications [1] Company Summary - The new subsidiary is fully owned by Watson Bio, indicating a strategic expansion into biotechnology and related fields [1] - The legal representative of the new company is Li Yunchun, which may suggest continuity in leadership and management practices [1] Industry Summary - The business scope of the new subsidiary includes research and application of cell technology, development of bio-based materials, manufacturing of bio-based materials, research on biological feed, and development of biological pesticides, highlighting a focus on sustainable and innovative biotechnological solutions [1]